Companies
BioGaia
Prodentis lozenges carrying two patented L. reuteri strains (ATCC PTA 5289 and DSM 17938), backed by 30+ years of probiotic research.
- Country
- Sweden
Commercial
Prodentis lozenges — L. reuteri ATCC PTA 5289 + DSM 17938 (two patented strains); 30+ years of probiotic research; Swedish
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | 1,538.2 million SEK | mb.cision.com · news.cision.com |
| Headcount | 242 employees | mb.cision.com · biogaiagroup.com |
| Production site | Eslöv, Sweden | mb.cision.com · biogaiagroup.com |
| Certification | HACCP food-safety approval | mb.cision.com |
| Certification | Good Manufacturing Practice (GMP) certificate from the Swedish Medical Products Agency | mb.cision.com |
Independent sources: mb.cision.com · news.cision.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Probiotic oral care | specialty-fine-chem | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.